Analytical Development & Quality Control (QC) Archives - Page 4 of 6 - BioQC

Analytical Development & Quality Control (QC)

Advertisement

Overcoming key challenges in understanding and implementing guideline ICH Q14 for Analytical Procedure Development

On-demand Presentation | Gain a comprehensive overview of ICH Q14 and understand the shifting regulatory landscape around analytical procedure development, including the balance between enhanced risk-based approaches and existing industry practices.

Improvement of Peak Integration in Capillary Electrophoresis: Reference Data Set No. 1

by BioQC Video Article

Marlon Krompholz | Explore the variability of manual peak integration and discover evidence-based strategies to improve analytical reproducibility.

A Comprehensive Evaluation of Analytical Method Parameters Critical to the Reliable Assessment of Therapeutic mRNA Integrity by Capillary Gel Electrophoresis

by BioQC Video Article

Meet the Expert: Dr. Huixin Lu | Understand how key method parameters, including denaturant type, LNP disruption strategy, and sample preparation, critically influence mRNA integrity results measured by CGE-LIF.

Quality Control in the (Bio)Pharmaceutical Industry: Safeguarding Medicines for Global Health

by BioQC Article

Industry Primer | Understand why rigorous quality control is essential across the pharmaceutical product lifecycle, and explore how QC approaches differ between small molecules, biologics, and advanced therapies such as cell and gene treatments.

Webinar

Analytical Quality by Design: Analytical Procedure Control Strategy (ACPS)

BioQC On-Demand Presentation by Dr. Lars Geurink (Batavia Biosciences) | Understand what the Analytical Procedure Control Strategy is under ICH Q14, how it connects every stage of method development into a coherent control framework…Understand what the Analytical Procedure Control Strategy is under ICH Q14, how it connects every stage of method development into a coherent control framework, and why "fit for purpose" is the correct standard for evaluating analytical procedures.

Webinar

ICH Q14 Analytical Procedure Development

BioQC On-Demand Presentation by Dr. Christof Finkler (F. Hoffmann-La Roche AG) | Understand the objectives and development history of ICH Q14, and learn how the minimal and enhanced approaches form a spectrum of increasing procedural understanding, lifecycle flexibility, and more suitably justified established conditions.

Expert Forum

Overcoming key challenges in understanding and implementing guideline ICH Q14 for Analytical Procedure Development

BioQC On-demand Presentation | Gain a comprehensive overview of ICH Q14 and understand the shifting regulatory landscape around analytical procedure development, including the balance between enhanced risk-based approaches and existing industry practices.

Article

Join the conversation (or start a discussion) on the BioQC user community

BioQC

Advertisement